Neoplasm. Malignant neoplasm of ovary
Conditions
Interventions
Cytoreductive surgery and intraperitoneal chemotherapy.
Treatment - Surgery
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with primary ovarian cancer who have not been previously treated for the cancer and in whom abdominal carcinomatosis is confirmed before or during surgical interventions. Exclusion criteria: Patient dissatisfaction; Patient intolerance;Lymph node metastasis; Systemic metastasis; No cytoreductive surgery (residue less than 1 cm); PS 70 years; Adhesions which are resistant to enterolysis.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease- free survival. Timepoint: At intervals of 6 and 9 months, and then every 3 months up to 5 yeras after intervention. Method of measurement: Month. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraperitoneal recurrence. Timepoint: In follow up studies. Method of measurement: Clinical or Paraclinical.;Surgical Complications. Timepoint: In early follow up studies. Method of measurement: Clinical or Paraclinical.;Ovarian cancer. Timepoint: In the follow up studies. Method of measurement: In biopsy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Abbas Abdollahi
Mashhad University of Medical Sciences
Outcome results
None listed